Precigen, Inc. ( PGEN) - Stock Earnings
PGEN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
PGEN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -23.5 million USD | 4.6 million USD |
| 2026Q1 | -7.9 million USD | 23.3 million USD |
| 2026Q2 | 20.1 million USD | 55.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PGEN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -95.9 million USD | 6.2 million USD |
| 2024 | -126.2 million USD | 3.9 million USD |
| 2025 | -250.6 million USD | 9.7 million USD |
| 2026 Est. | — | — |
PGEN
Price: $7.36
Earnings Per Share: -1.07 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4.3 million
Market Capitalization: 3.0 billion